An ophthalmic pharmaceutical company, focused on the development and commercialization of products for serious diseases and conditions of the eye.
The best Bull and Bear pitches based on recency and number of recommendations.
I'm an eye doc so I have a little insight into the core products offered by ISTA. Their beta-blocker Istalol is just an okay product, but I'm very optimistic about the future of their other product Xibrom, which is a non-steroidal anti-inflammatory… More
ISTA has surprisingly maintained the dramatic elevation in share price that came about due to Valeant's takeout bid, despite the fact that Valeant has moved on from the stalled negotiations and purchased Eyetech instead. The share price is nearly… More
Read the most recent pitches from players about ISTA.DL.
Find the members with the highest scoring picks in ISTA.DL.
See what the Wall Street professionals think, according to their public statements and filings.